New York State Common Retirement Fund’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-220,600
Closed -$25K 3190
2018
Q4
$25K Hold
220,600
﹤0.01% 3148
2018
Q3
$375K Hold
220,600
﹤0.01% 2554
2018
Q2
$384K Sell
220,600
-4,000
-2% -$6.92K ﹤0.01% 2568
2018
Q1
$411K Buy
224,600
+4,000
+2% +$8.45K ﹤0.01% 2435
2017
Q4
$492K Hold
220,600
﹤0.01% 2367
2017
Q3
$640K Hold
220,600
﹤0.01% 2239
2017
Q2
$982K Buy
220,600
+17,799
+9% +$73.4K ﹤0.01% 2054
2017
Q1
$945K Buy
202,801
+25,501
+14% +$148K ﹤0.01% 2061
2016
Q4
$1.08M Hold
177,300
﹤0.01% 2001
2016
Q3
$977K Buy
177,300
+80,000
+82% +$375K ﹤0.01% 2004
2016
Q2
$370K Hold
97,300
﹤0.01% 2414
2016
Q1
$269K Sell
97,300
-29,747
-23% -$108K ﹤0.01% 2544
2015
Q4
$720K Hold
127,047
﹤0.01% 2145
2015
Q3
$673K Buy
127,047
+13,690
+12% +$106K ﹤0.01% 2175
2015
Q2
$941K Buy
+113,357
New +$549K ﹤0.01% 2213

Other funds holding SGYP

New York State Common Retirement Fund's SGYP Position: Q1 2019 in Review

New York State Common Retirement Fund sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2019, closing a stake of 220,600 shares — an estimated $25K sold.

New York State Common Retirement Fund first reported a position in SGYP in Q2 2015 and held it in 15 quarters. The position peaked at $1.08M in Q4 2016. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • New York State Common Retirement Fund reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2019 after selling out during the quarter.
  • New York State Common Retirement Fund sold 220,600 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2019, an estimated $25K.
  • New York State Common Retirement Fund first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and held it in 15 quarters.
  • New York State Common Retirement Fund's Synergy Pharmaceuticals, Inc Common Stock position peaked at $1.08M in Q4 2016.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2019.

Based on New York State Common Retirement Fund's 13F filing for Q1 2019, filed 8 May 2019.